By Dr. Susan Lin, MD | MD HAIR | La Cañada Ventures, Inc.
You have read the word “antioxidant” so many times it has stopped meaning anything. It is on your serum, your smoothie, your sunscreen, your tea. Somewhere along the way it became a decoration — a word brands print because it tests well, not because anyone expects you to ask what it does.
So you have mentally filed antioxidants under nice to have. Vitamins for your face. Pleasant, optional, probably harmless. Meanwhile the actual thinning — the widening part, the shorter ponytail — feels like it must be about hormones, and hormones feel like the serious conversation.
I want to reopen that file. Because in the hair follicle specifically, oxidative stress is not a wellness abstraction. It is a measurable, mechanistically documented driver of premature cycle termination, cell death in the follicle’s growth compartment, and pigment loss. It sits underneath the hormonal story rather than beside it.
I am Dr. Susan F. Lin, M.D. — physician formulator behind the MD® line at La Cañada Ventures, Inc., trained at Boston University School of Medicine, board-certified in Obstetrics & Gynecology and in Anti-Aging Medicine (A4M), and formulating for hair and skin since 2008. Anti-aging medicine is, at its scientific core, the study of cumulative cellular damage. Let me show you what that damage looks like inside a hair follicle, and why I take the antioxidant column of a formula as seriously as the DHT column.
The Follicle Is a Metabolic Furnace — And Furnaces Produce Exhaust
Start with an underappreciated fact: the anagen hair follicle is among the most metabolically demanding structures in the human body.
The hair matrix — the ring of cells at the base of the follicle that manufactures the hair shaft — contains some of the fastest-proliferating cells you own, dividing every 18 to 24 hours during active growth. That output is expensive. Building a keratinized fiber requires enormous ATP throughput, and ATP is produced in mitochondria through oxidative phosphorylation.
Here is the catch built into the chemistry. Mitochondrial respiration is not perfectly efficient. A fraction of the oxygen consumed leaks out as partially reduced intermediates: superoxide, hydrogen peroxide, hydroxyl radical — collectively reactive oxygen species (ROS). Every cell making energy makes ROS. A cell making a great deal of energy makes a great deal of ROS.
So the follicle’s greatest strength is also its structural vulnerability. It runs hot, and running hot generates exhaust.
The Redox Balance
ROS are not simply villains. At low concentrations they serve as signaling molecules that help regulate proliferation and differentiation. The body maintains an elaborate defense system to keep them in the useful range: enzymatic scavengers such as superoxide dismutase, catalase, and glutathione peroxidase, plus small-molecule antioxidants including glutathione, vitamin C, vitamin E, and ergothioneine.
Oxidative stress is the name for what happens when production outruns that defense. Excess ROS begin reacting indiscriminately with whatever is nearby — peroxidizing membrane lipids, oxidizing protein side chains, damaging mitochondrial and nuclear DNA. Trüeb’s review of oxidative stress in hair aging lays out the case that this imbalance is a significant contributor to follicle senescence, and that the follicle’s own high metabolic rate is what places it at elevated risk (Trüeb, 2009).
The scalp compounds the problem: it is horizontally oriented, receives more cumulative UV than almost any other skin site, and sits at the top of the body where airborne particulate settles.
What Oxidative Stress Actually Does to a Growing Follicle
1. It Terminates Anagen Early
The hair cycle is not a timer. It is a negotiated decision made continuously by the follicle based on signals about its condition. Anagen — the growth phase — persists as long as the follicle judges the environment supportive; catagen, the regression phase, is triggered when it does not.
Oxidative stress is one of the signals that flips that switch. In experimental models, exposing follicles to oxidative insult accelerates entry into catagen — cutting short the phase in which the hair shaft is actually being built (Naito et al., 2008). Peters and colleagues, probing stress-mediator signaling directly in human hair follicles, showed that such stress inputs promote premature catagen induction and apoptosis within the follicular epithelium (Peters et al., 2007).
Understand what that means functionally. A follicle whose anagen phase is repeatedly cut short produces a shorter, thinner fiber each cycle and spends a greater proportion of its life resting. Its cycle-time arithmetic shifts against you. There is no dramatic event — just a slow reduction in how much hair the same follicle count delivers.
2. It Kills Cells in the Growth Compartment
The follicle regresses through apoptosis — programmed cell death in the matrix keratinocytes. Apoptosis in catagen is normal and necessary; it is how the follicle disassembles its lower portion before rebuilding.
Oxidative damage lowers the threshold for triggering it. Mitochondria are both a source of ROS and a sensor of it: sufficiently damaged mitochondria release cytochrome c and initiate the apoptotic cascade directly. A follicle under chronic oxidative load is a follicle in which the demolition sequence is easier to start and harder to stop.
3. It Attacks the Pigment Cells First
If you want visible proof that oxidative stress operates in human hair, look at graying.
Follicular melanocytes — the cells that pigment your hair — are unusually exposed. Melanin synthesis itself generates ROS as a byproduct, so these cells work in a pro-oxidant environment by occupational necessity. And unlike matrix keratinocytes, they must survive across cycles.
Wood and colleagues demonstrated that hydrogen peroxide accumulates in the graying human hair follicle, and that the follicle’s capacity to repair oxidation-damaged proteins declines with age — specifically, methionine sulfoxide repair falters, leaving key enzymes in the pigmentation pathway oxidized and non-functional. The result is loss of pigment production from within the follicle (Wood et al., 2009).
Gray hair is not a metaphor for oxidative stress. It is a direct clinical readout of it.
Where the Oxidative Load Comes From
Ultraviolet radiation. UV generates ROS directly in scalp tissue and degrades the hair shaft’s own protein and lipid structure. Part lines and thinning zones lose the fiber density that normally shades the scalp — so the areas that most need protection get the most exposure.
Airborne pollution. Particulate matter and polycyclic aromatic hydrocarbons deposit on scalp skin and generate ROS. Krutmann and colleagues formalized the “skin aging exposome,” identifying pollution alongside UV as a documented environmental contributor to cutaneous oxidative damage (Krutmann et al., 2017).
Smoking. Cigarette smoke delivers oxidants directly and impairs microcirculation. A community-based survey found a statistically significant association between smoking status and androgenetic alopecia in men, with oxidative injury and microvascular compromise among the mechanisms proposed (Su & Chen, 2007).
Endogenous load. Chronic inflammation, psychological stress, poor sleep, metabolic dysfunction, and simple chronological aging all raise systemic ROS while antioxidant defenses decline with age.
None of this replaces the hormonal story. Oxidative stress and androgen-driven miniaturization are not competing explanations — they are collaborating ones. Perifollicular inflammation associated with androgenetic alopecia is itself a ROS-generating process, which is precisely why I have never been comfortable formulating a DHT-pathway product with no antioxidant architecture behind it.
The Antioxidant Actives With Follicle-Relevant Literature
Now the useful part: which antioxidants have research that actually touches hair biology. I will be explicit about the level of evidence in each case, because “has literature” and “is proven to regrow hair” are different sentences and I refuse to blur them.
Ergothioneine
A naturally occurring thiol amino acid derivative, obtained from diet and concentrated in tissues by a dedicated transporter (OCTN1) — a transporter is strong biological evidence that the body considers a molecule worth retaining. Cheah and Halliwell’s review characterizes it as an unusually stable cytoprotective antioxidant that accumulates in tissues under oxidative stress (Cheah & Halliwell, 2012). Its follicle-specific literature is limited; its cytoprotective profile is well described.
Glutathione
The cell’s principal endogenous antioxidant and the substrate for glutathione peroxidase. Glutathione status declines with age and under chronic oxidative load, and it sits directly in the pathway that clears hydrogen peroxide — the same species implicated in follicular graying (Wood et al., 2009).
EGCG (Green Tea Catechin)
The most-studied polyphenol in follicle research. Kwon and colleagues reported in an ex vivo human hair follicle organ culture model that EGCG promoted follicle growth, with the authors describing effects on proliferation in the dermal papilla region (Kwon et al., 2007). I want to be precise: this is an ex vivo organ-culture finding, not a clinical trial result.
Tocotrienols (Vitamin E Family)
The most interesting human data in this section. Beoy and colleagues conducted an eight-month supplementation study in volunteers with hair loss and reported a significant increase in hair number in the tocotrienol group versus placebo, attributing the effect to reduction of lipid peroxidation in the scalp (Beoy et al., 2010). It was a small study, and I would not build a claim on it — but it is a genuine human trial of an antioxidant hypothesis in hair, and it deserves to be known.
Verbascoside
The phenylethanoid glycoside from lilac at the center of the MD® formulation philosophy. Its antioxidant credentials are the most consistently documented aspect of its pharmacology across decades of phytochemistry: the comprehensive review in Biotechnology Advances catalogues its free-radical-scavenging activity across numerous laboratory models (Alipieva et al., 2014).
What makes verbascoside distinctive in this list is that its two research stories run in parallel. It is documented as an antioxidant, and it has been examined in the cells of the follicle itself. In controlled laboratory studies on human dermal papilla cells, verbascoside induced cell proliferation, prevented testosterone-induced cell death, and reduced the release of pro-inflammatory signals including IL-1α, IL-6, IL-1β and TNF-α (Wisuitiprot et al., 2022). Both are laboratory-level characterizations, described here as exactly that — cell studies, not human trials, and the authors of that paper say plainly that clinical study is still needed. I will add one detail most brands would leave out: that work used verbascoside extracted from Acanthus, not from lilac. Same molecule, different plant. It is not a study of our material, and I am not going to present it as one.
The Bottom Line
The hair follicle is one of the most metabolically active structures in the body, and that metabolic intensity generates reactive oxygen species as an unavoidable byproduct. When ROS production outpaces antioxidant defense, the consequences are specific and documented: premature entry into catagen, apoptosis in the matrix compartment, and oxidative failure of the pigment machinery that shows up as graying (Trüeb, 2009; Wood et al., 2009).
Environmental load — UV, pollution, smoking — stacks on top of endogenous production, and the scalp is anatomically among the most exposed sites you have. This is not an alternative to the hormonal explanation of hair thinning. It runs underneath it, and the inflammation that accompanies androgenetic miniaturization generates ROS of its own.
Antioxidants earn their place in a serious hair formulation not as label decoration but as a second, complementary line of defense for tissue that is chemically guaranteed to be under oxidative load every day it is doing its job. That is why I formulate them in — and why I describe their evidence at the level it actually exists.
Dr. Susan Lin’s Clinical Perspective
“Anti-aging medicine taught me to think in terms of cumulative damage rather than single events, and no tissue illustrates that better than the hair follicle. Patients arrive convinced their thinning is purely hormonal, and they are partly right — but the follicle they want me to protect is a high-output metabolic organ generating oxidative byproducts continuously, sitting on the most UV-exposed skin on the body, under an inflammatory load that produces still more. Graying is the proof, visible in the mirror: oxidation of the pigment machinery, documented at the molecular level. I do not tell patients an antioxidant will regrow their hair, because the evidence does not support that sentence. I tell them that reducing oxidative burden protects the environment the follicle has to live in — and that a formula addressing DHT while ignoring redox is doing half a job.”
— Dr. Susan F. Lin, M.D., Physician Formulator, MD HAIR
Mechanism Spotlight: Lipid Peroxidation and the Catagen Switch
Of all the damage ROS inflict, lipid peroxidation is the most self-propagating. A hydroxyl radical abstracts a hydrogen atom from a polyunsaturated fatty acid in a cell membrane, creating a lipid radical; that radical reacts with oxygen to form a lipid peroxyl radical, which abstracts a hydrogen from the next fatty acid along — and so on. One initiating event becomes a chain reaction that runs through a membrane until an antioxidant such as vitamin E or a tocotrienol intercepts it. The consequences for a follicle are structural and immediate: peroxidized membranes lose integrity, mitochondrial membranes leak, and the leak releases the signals that initiate apoptosis. Experimental work applying lipid peroxides to follicles has reported earlier onset of catagen — the regression phase — implicating peroxidation not merely as damage but as an active input to the follicle’s cycling decision (Naito et al., 2008). This is also the most coherent reading of the tocotrienol result: tocotrienols are chain-breaking, membrane-resident antioxidants whose defining function is to terminate exactly this reaction, and the authors of that human supplementation study attributed the hair-count change to reduced scalp lipid peroxidation (Beoy et al., 2010). Chain-breaking chemistry at the membrane, cycling consequences at the follicle.
Recommended Reading
Pillar pages on mdhair.com:
- The Scalp Health Guide
- The Lilac & Verbascoside Story
- Drug-Free Hair Loss Treatment — The Complete Guide
- Our Clinical Evidence
- Meet Dr. Susan Lin, MD
Related articles in this series:
- 5-Alpha Reductase Explained: How Pharmaceutical and Botanical DHT Inhibition Actually Differ — the androgen half of the picture, and how the inflammation it drives feeds the oxidative load described here
- Your Part Line Is Skin: Scalp Sun Damage and Why It Matters — the UV component of the exposome, up close
- Verbascoside and the Dermal Papilla: What the Cell Studies Actually Show — the full account of the laboratory work described above
Not sure where your hair loss fits? Take the MD HAIR Quiz.
Our official sister site, md-factor.com, carries the broader MD® science library, including the antioxidant and skin-barrier research behind the wider portfolio.
MD HAIR Product Recommendation
MD® Scalp Essential — Anti-Aging Scalp Serum
If the argument of this article is that the follicle lives in a chemically hostile neighborhood, then MD® Scalp Essential is the product I formulated to improve the neighborhood. It is our leave-in scalp-environment serum, built around mandelic acid, caffeine, and lilac stem-cell extract with CLA glutathione — the standardized source of verbascoside, the phenylethanoid glycoside whose free-radical-scavenging capacity is the most consistently documented aspect of its laboratory profile (Alipieva et al., 2014), and which in laboratory studies on human dermal papilla cells also reduced the release of pro-inflammatory signals including IL-1α, IL-6, IL-1β and TNF-α (Wisuitiprot et al., 2022).
I designed it for the surface where the load actually lands: the scalp skin that takes the UV, the particulate, and the perifollicular inflammation. It is drug-free and hormone-free, physician-formulated by Dr. Susan F. Lin, M.D., and manufactured in FDA-registered, GMP-compliant facilities in the USA. MD® Scalp Essential is a cosmetic product and is not intended to diagnose, treat, cure, or prevent any disease.
Also consider: MD Nutri Hair™
Oxidative and inflammatory load is not only a surface problem, which is why I pair the topical with the internal input rather than choosing between them. MD Nutri Hair™ carries the same standardized lilac verbascoside in capsule form — the molecule that, in laboratory studies on human dermal papilla cells, reduced the release of pro-inflammatory signals including IL-1α, IL-6, IL-1β and TNF-α, and prevented testosterone-induced death of those cells. One capsule daily, alongside the topical that supports the scalp environment itself. In a 30-day in-office consumer use study of MD Nutri Hair™ (30 subjects, outcomes self-reported), 95% saw improved hair appearance, 90% reported better manageability, and 75% reported increased fullness. Individual results vary. As a dietary supplement, MD Nutri Hair™ is not intended to diagnose, treat, cure, or prevent any disease, and it is not FDA approved — no dietary supplement is.
Genuine MD HAIR and MD Nutri Hair™ products are sold only through mdhair.com, md-factor.com, and the official La Cañada Ventures, Inc. stores on Amazon and Walmart — the only channels where we can vouch for lot integrity and storage.
References
- Trüeb RM. (2009). Oxidative stress in ageing of hair. International Journal of Trichology, 1(1), 6–14. PubMed
- Wood JM, Decker H, Hartmann H, et al. (2009). Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB Journal, 23(7), 2065–2075. PubMed
- Peters EM, Liotiri S, Bodó E, et al. (2007). Probing the effects of stress mediators on the human hair follicle: substance P holds central position. American Journal of Pathology, 171(6), 1872–1886. PubMed
- Naito A, Midorikawa T, Yoshino T, Ohdera M. (2008). Lipid peroxides induce early onset of catagen phase in murine hair cycles. International Journal of Molecular Medicine, 22(6), 725–729. PubMed
- Beoy LA, Woei WJ, Hay YK. (2010). Effects of tocotrienol supplementation on hair growth in human volunteers. Tropical Life Sciences Research, 21(2), 91–99. PubMed
- Kwon OS, Han JH, Yoo HG, et al. (2007). Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG). Phytomedicine, 14(7–8), 551–555. PubMed
- Cheah IK, Halliwell B. (2012). Ergothioneine; antioxidant potential, physiological function and role in disease. Biochimica et Biophysica Acta, 1822(5), 784–793. PubMed
- Alipieva K, Korkina L, Orhan IE, Georgiev MI. (2014). Verbascoside — a review of its occurrence, (bio)synthesis and pharmacological significance. Biotechnology Advances, 32(6), 1065–1076. PubMed
- Krutmann J, Bouloc A, Sore G, Bernard BA, Passeron T. (2017). The skin aging exposome. Journal of Dermatological Science, 85(3), 152–161. PubMed
- Su LH, Chen TH. (2007). Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey. Archives of Dermatology, 143(11), 1401–1406. PubMed
- Wisuitiprot V, et al. (2022). Effects of Acanthus ebracteatus Vahl. extract and verbascoside on human dermal papilla and murine macrophage. Scientific Reports, 12, 1491. PubMed
Dr. Susan F. Lin, M.D. is the physician formulator behind MD HAIR and MD Nutri Hair™, product lines of La Cañada Ventures, Inc. — physician-formulated since 2008 under the MD® mark. She trained at Boston University School of Medicine, is board-certified in Obstetrics & Gynecology and in Anti-Aging Medicine (A4M), and is the named inventor on U.S. Patent No. 8,206,695 (the MD® lash formulation).
MD HAIR topical products are cosmetics manufactured in FDA-registered, GMP-compliant facilities; facility registration is not product approval by the FDA. MD Nutri Hair™ is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. In vitro and ex vivo findings described in this article are laboratory characterizations of ingredient mechanism and are not clinical outcomes. Individual results vary. This article is for educational purposes and does not constitute medical advice. Consult your own physician for personalized guidance. Because there are no clinical data in pregnant or breastfeeding women, we do not advocate using MD HAIR products during pregnancy or lactation.